| abstract |
Biphenylsulfonylcyanamides of the formula I in which they are presentnindividual general symbols meanings defined in the description, anphysiologically acceptable salts thereof. These compounds exhibitn“Excellent antiarrhythmic properties with cardioprotective component.n. These compounds can prevent or strongly inhibitnto reduce pathophysiological processes in ischemic formationninduced disorders, especially at ischemic originninduced cardiac arrhythmias. In addition, they show strongninhibitory effect on cell proliferation. A pharmaceutical is disclosedncompositions comprising the same. |